Literature DB >> 17893426

In vitro studies to show sequestration of matrix metalloproteinases by silver-containing wound care products.

Michael Walker1, Philip G Bowler, Christine A Cochrane.   

Abstract

Excess or "uncontrolled" proteinase activity in the wound bed has been implicated as one factor that may delay or compromise wound healing. One proteinase group--matrix metalloproteinases--includes collagenases, elastase, and gelatinases and can be endogenous (cell) or exogenous (bacterial) in origin. A study was conducted to assess the ability of five silver-containing wound care products to reduce a known matrix metalloproteinase supernatant concentration in vitro. Four silver-containing wound dressings (a carboxy-methyl cellulose, a nanocrystalline, a hydro-alginate, and a collagen/oxidized regenerated cellulose composite dressing), along with a 0.5% aqueous silver nitrate [w/v] solution and controls for matrix metalloproteinase-2 and matrix metalloproteinase-9 sourced from ex vivo dermal tissue and blood monocytes, respectively, were used. Extracts were separated and purified using gelatine-Sepharose column chromatography and dialysis and polyacrylamide gel electrophoretic zymography was used to analyze specific matrix metalloproteinase activity. All dressings and the solution were shown to sequester both matrix metalloproteinases. The silver-containing carboxy-methyl cellulose dressing showed significantly greater sequestration for matrix metalloproteinase-2 at 6 and 24 hours (P< 0.001) compared to the other treatments. For matrix metalloproteinase-9, both the carboxy-methyl cellulose dressing and the oxidized regenerated cellulose dressing achieved significant sequestration when compared to the other treatments at 24 hours (P <0.001), which was maintained to 48 hours (P < 0.001). Results from this study show that silver-containing dressings are effective in sequestering matrix metalloproteinase-2 and -9 and that this can be achieved without a sacrificial protein (eg, collagen). Although the varying ability of wound dressings to sequester matrix metalloproteinases has been shown in vitro, further in vivo evidence is required to confirm these findings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893426

Source DB:  PubMed          Journal:  Ostomy Wound Manage        ISSN: 0889-5899            Impact factor:   2.629


  7 in total

1.  Acticoat™ stimulates inflammation, but does not delay healing, in acute full-thickness excisional wounds.

Authors:  Carol A Hartmann; Heinz Rode; Beverley Kramer
Journal:  Int Wound J       Date:  2015-11-11       Impact factor: 3.315

2.  Alginate membranes loaded with hyaluronic acid and silver nanoparticles to foster tissue healing and to control bacterial contamination of non-healing wounds.

Authors:  Lorena Tarusha; Sergio Paoletti; Andrea Travan; Eleonora Marsich
Journal:  J Mater Sci Mater Med       Date:  2018-02-02       Impact factor: 3.896

3.  A review of the applications of the hydrofiber dressing with silver (Aquacel Ag) in wound care.

Authors:  Yoav Barnea; Jerry Weiss; Eyal Gur
Journal:  Ther Clin Risk Manag       Date:  2010-02-02       Impact factor: 2.423

Review 4.  Proteases and Delayed Wound Healing.

Authors:  Sara M McCarty; Steven L Percival
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-10       Impact factor: 4.730

5.  Arresting simulated dentine caries with adjunctive application of silver nitrate solution and sodium fluoride varnish: an in vitro study.

Authors:  Irene Shuping Zhao; May Lei Mei; Quan-Li Li; Edward Chin Man Lo; Chun-Hung Chu
Journal:  Int Dent J       Date:  2017-03-22       Impact factor: 2.607

6.  The role of polyphosphates in the sequestration of matrix metalloproteinases.

Authors:  Sara M McCarty; Steven L Percival; Peter D Clegg; Christine A Cochrane
Journal:  Int Wound J       Date:  2013-04-17       Impact factor: 3.315

Review 7.  Chitosan based metallic nanocomposite scaffolds as antimicrobial wound dressings.

Authors:  Annapoorna Mohandas; S Deepthi; Raja Biswas; R Jayakumar
Journal:  Bioact Mater       Date:  2017-11-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.